Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
0.9196
+0.0304 (3.42%)
At close: Sep 17, 2026, 4:00 PM EDT
0.9200
+0.0004 (0.04%)
After-hours: Sep 17, 2026, 4:41 PM EDT
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $129.58 million as of September 17, 2026. Its market cap has decreased by -32.13% in one year.
Market Cap
129.58M
Enterprise Value
100.80M
1-Year Change
-32.13%
Ranking
Category
Stock Price
$0.92
ChartMarket Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $129.58M, a decrease of -64.35%. That is a compound annual growth rate of -13.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 129.58M | -36.85% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 143.45M |
| LENZ Therapeutics | 140.45M |
| Caribou Biosciences | 138.30M |
| Conexeu Sciences | 133.79M |
| Equillium | 132.84M |
| TuHURA Biosciences | 130.64M |
| Biomea Fusion | 129.02M |
| Cellectis | 126.27M |